Hereditary Hemorrhagic Telangiectasia: Vascular Biology - and Pathophysiology - Workshop Presentation Slides

Hereditary Hemorrhagic Telangiectasia: Vascular Biology
and Pathophysiology

Workshop Presentation Slides

June 8 Presentations

• Transforming growth factor-? pathway and HHT
  Carmelo Bernabeu, Ph.D.
  Centro Investigaciones Biológicas, CSIC
• Genetic variation in TGF?1 dependency for vascular development
  Rosemary J. Akhurst, Ph.D.
  University of California, San Francisco
  Mt. Zion Cancer Research Institute
• BMP9 is a potent activator of ALK1 signalling in endothelial cells
  Sabine Bailly, Ph.D.
  INSERM
• Vascular Biology and HHT
  Michelle Letarte, Ph.D.
  The Hospital for Sick Children
• Alk1 signaling favors resolution in the zebrafish endothelium
  Beth Roman, Ph.D.
  Georgetown University Medical Center
• Endoglin has a crucial role in blood cell-mediated vascular repair
  Linda W. van Laake
  Hubrecht Laboratory
  Netherlands Institute for Developmental Biology
• Endothelial Biology of PAH and HHT: A "Genotype"-Phenotype Assessment
  Duncan John Stewart, M.D.
  St. Michael's Hospital
  University of Toronto
• Endothelial O-glycans are essential for angiogenesis
  Lijun Xia
  Oklahoma Medical Research Foundation
• Characterization of Endothelial cells from Hereditary Haemorrhagic Telangiectasia patients
  Africa Fernandez-Lopez
  Centro Investigaciones Biológicas, CSIC
• Small Molecules and Chemical Genomics: Tools for Understanding HHT?
  Christopher Austin, M.D.
  National Human Genome Research Institute
  National Institutes of Health

June 9 Presentations

• Organ Pathophysiology The Human Model
  Marie E. Faughnan, M.D., M.S.C.
  St. Michael's Hospital
• Abnormal Development of Retinal Vasculature and Retinal Neovascularization During Oxygen-Induced Ischemic Retinopathy in Endoglin Heterozygous Mice
  Nader Sheibani, Ph.D.
  University of Wisconsin

All presentation slides are in format. To view, download the free Adobe Reader.